Baricitinib Compared to Standard Therapy in Patients With COVID-19
NCT04393051
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
126
Enrollment
OTHER
Sponsor class
Conditions
Covid-19
SARS-CoV 2
SARS Pneumonia
Interventions
DRUG:
Baricitinib Oral Tablet
Sponsor
Azienda Ospedaliero, Universitaria Pisana